Zanamivir for Inhalation (Relenza)

Awarded Award Notice Posted

Solicitation number
SPE2DP22R0002
Agency
Medical Supply Chain Troop Support, Department of Defense
Awarded
to Glaxosmithkline, LLC
Set-aside
No set-aside

Opportunity facts

Contract number
SPE2DP-22-D-0009 Federal IDV award
NAICS code
Not on record
PSC
Not on record

Notice details come from SAM.gov. Updated .

Notice text

As posted on SAM.gov.

This contract was a firm fixed priced action for acquisition of Zanamivir for Inhalation (Relenza).  This contract was awarded under the applicable statutory authority permitting Other Than Full and Open Competition, 10 U.S.C. 2304(c)(1), as implemented by FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.

Awarded contract SPE2DP-22-D-0009 to GLAXOSMITHKLINE LLC for 4593750.00 on 2022-09-13.

Notice history

Notice Type Posted
Zanamivir for Inhalation (Relenza) This notice · Latest Award Notice
Zanamivir for inhal Award Notice
Zanamivir for Inhalation (Relenza) Latest pre-solicitation Pre-Solicitation
Zanamivir for Inhalation (Relenza) Original Pre-Solicitation

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity
Try for free Login